Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Mackerel-derived fermented fish oil helps hair grow by activating growth pathways and increasing cell proliferation.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Exosomes from stem cells may help rejuvenate skin and regrow hair, but more research is needed.

Older mice have stiffer skin with less elasticity due to changes in collagen and skin structure, affecting aging and hair loss.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Macrophages help regrow hair by activating stem cells using AKT/β-catenin and TNF.

Notch signaling disruptions can cause various skin diseases.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Skin stem cells interacting with their environment is crucial for maintaining and regenerating skin and hair, and understanding this can help develop new treatments for skin and hair disorders.

Pantethine may boost the immune system's ability to fight sarcoma.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Drug repurposing shows promise for treating many medical conditions.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Apple extract called procyanidin B-2 was found to greatly increase hair growth.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Spin traps like PBN could protect skin from pollution and sunlight in cosmetics but need more research for safe use.